• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Hims & Hers Now Offers In-person Care in Connecticut with Hartford Healthcare Partnership

Share:

January 13, 2024

Health and wellness platform Hims & Hers Health has announced a strategic partnership with Hartford HealthCare (HHC), Connecticut’s transformative health system. The collaboration enhances patient access to in-person healthcare services, allowing Hims & Hers medical providers to seamlessly refer patients to HHC’s primary and specialty care provider network when needed. The partnership expands Hims & Hers’ medical system partner network to 11 states and Washington, D.C., emphasizing high-quality care with a focus on cardiovascular health through HHC’s renowned Heart & Vascular Institute.

Hims & Hers Health, Inc., the leading health and wellness platform, and Connecticut’s most transformative health system, Hartford HealthCare (HHC), today announced a strategic partnership that broadens access to in-person healthcare services.
The collaboration provides patients with an enhanced and connected healthcare experience when they need care outside the Hims & Hers platform. Licensed medical providers on the platform will be able to seamlessly refer patients to HHC’s distinguished primary and specialty care provider network, when necessary. This can include when Hims & Hers customers have more complex health histories or medical needs, those that may require additional in-person follow-up care or evaluations or are in need of care for conditions not currently supported by the Hims & Hers platform

Enhancing Specialized Care: A Focus on Cardiovascular Health with HHC

Hims & Hers reinforces its commitment to accessible, high-quality care by integrating the esteemed Connecticut-based healthcare system, HHC, into its growing provider network. With this addition, the company’s medical system partner network now spans 11 states and Washington, D.C.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

As Hims & Hers expands into personalized treatments, such as Heart Health by Hims and Weight Loss by Hims & Hers, the inclusion of HHC further strengthens the company’s emphasis on quality care. HHC’s renowned Heart & Vascular Institute, a national leader in cardiovascular disease care, offers personalized treatments and advanced cardiac procedures, making it a significant addition to the expanding network.

“We partnered with Hartford HealthCare because of its unwavering commitment to delivering exceptional care, embracing innovation, and fostering a culture of compassion,” said Hims & Hers Chief Medical Officer Patrick Carroll, MD. “With a focus on patient well-being, cutting-edge treatments, and a dedicated team of healthcare professionals, we know our customers in Connecticut will always receive the best care when they need to see a specialist for treatment beyond our platform.”

Source: Bio Space

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • EasyHealth Secures $135M to Redesign Medicare ExperienceEasyHealth Secures $135M to Redesign Medicare Experience
  • Voro Raises $2.5M To Bring Trusted Reviews And Referrals Of DoctorsVoro Raises $2.5M To Bring Trusted Reviews And Referrals Of Doctors
  • Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate CancerBlue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer
  • B2B Digital Health Platform Peppy Raises £6.6M Series a FundingB2B Digital Health Platform Peppy Raises £6.6M Series a Funding
  • FDA Grants Breakthrough Designation to RenalytixAI for AI-Enabled Diagnostic for Kidney DiseaseFDA Grants Breakthrough Designation to RenalytixAI for AI-Enabled Diagnostic for Kidney Disease
  • Medable Raises $91M for Global Decentralized Clinical Trials PlatformMedable Raises $91M for Global Decentralized Clinical Trials Platform
  • Boston Scientific Closes Claret Medical Acquisition, Announces Positive Reimbursement DecisionBoston Scientific Closes Claret Medical Acquisition, Announces Positive Reimbursement Decision
  • Alfasigma Acquires the Entire Share Capital of Sofar, An Italian Pharmaceutical CompanyAlfasigma Acquires the Entire Share Capital of Sofar, An Italian Pharmaceutical Company

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications